Knight Therapeutics | GUD - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
Akebia Therapeutics USD 10.34M 441K 2025-12
Alaunos Therapeutics USD 0 18K 2024-09
Aurora Cannabis CAD 8.22M 80.38M 2026-03
Avita Medical AUD 3.3M 166K 2025-12
Canopy Growth CAD 62.98M 9.91M 2026-03
Cronos Group USD 26.48M 2.26M 2026-03
Ionis Pharmaceuticals USD 3M 5M 2026-03
IQVIA Holdings USD 3.08B 161M 2026-03
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Moderna USD 955M 503M 2026-03
Omeros USD 33.16M 18.52M 2024-06
Organigram Holdings CAD 43.39M 13.54M 2026-03
Organon & Co USD 677M 89M 2026-03
Revvity USD 323.46M 26.93M 2026-03
Tilray USD 164.37M 8.41M 2025-09
Viatris USD 2.36B 195.9M 2026-03
Xeris Pharmaceuticals USD 10.57M 3.08M 2026-03